Companies go long by investing in longevity

Investments in research and treatments aimed at creating an ostensible fountain of youth are booming

May 17, 2015 @ 12:01 am

By Liz Skinner

A dizzying number of research institutes, wealthy entrepreneurs and companies, including Google Inc., are investing in research and treatments aimed at creating an ostensible fountain of youth.

Google and Arthur Levinson, Genentech's former chief executive, created a private research and development company two years ago called Calico. The biotech is focused on aging research and therapeutics, and it is partnering with pharmaceutical firm AbbVie to develop and market drugs for the diseases most associated with aging.

Most recently Calico said it is pairing with the Buck Institute for Research on Aging to support studies of longevity. The Buck Institute houses 21 independent laboratories that explore ways to lengthen the healthy lifespan of people; what it calls “healthspan.”

The institute advocates merging research on age-related diseases with continuing studies on human chronic disease.

Integrated approach

“What has come out of our work is a keen understanding that the factors driving aging are highly intertwined, and that in order to extend healthspan we need an integrated approach to health and disease with the understanding that biological systems change with age,” said Brian Kennedy, chief executive of the Buck Institute.

In a separate effort, Joon Yun, the president of health care investment firm Palo Alto Investors, is sponsoring a $1 million Palo Alto Longevity Prize, which will reward scientists who can resolve especially tricky challenges of aging in research animals.

Genomics guru Craig Venter and innovation specialist Peter Diamandis founded Human Longevity Inc., a company using genome data and analytics to fight the diseases that shorten and degrade human life.

And venture capitalist Peter Thiel began funding longevity research nearly a decade ago.

His Thiel Foundation backs the SENS Research Foundation, which is headed by Aubrey de Grey, one of the early scientists to say life spans of 120 or more years could be right around the corner.


What do you think?

View comments

Most watched


Young professionals see lots of opportunity to reinvent the advice experience

Members of the 2019 InvestmentNews class of 40 Under 40 have strategies to overcome the challenges of being young in a mature industry.


Young advisers envision a radically different business in five years

Fintech and sustainable investing are two factors being watched closely by some of the 2019 class of InvestmentNews' 40 Under 40.

Latest news & opinion

Vermont establishes restitution fund for victims of investment fraud

Portion of settlements with financial perpetrators would supply the pool.

10 IBDs with the most variable annuity revenue

Although the popularity of VAs has declined in recent years, some independent broker-dealers still do a good business in them.

Target-date fund design may be wrong for retirees

Researchers suggest the funds don't adequately hedge against sequence-of-returns risk in retirement.

InvestmentNews' 2019 class of 40 Under 40

Our 40 Under 40 project, now in its sixth year, highlights young talent in the financial advice industry. These individuals illustrate the tremendous potential of those coming up in the profession. These stories will surprise, entertain, educate and inspire.

New Jersey fiduciary rule: Pressure leads to public hearing, comment deadline extension

Industry push results in chance to air grievances on July 17 and another month to present objections.


Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting It'll help us continue to serve you.

Yes, show me how to whitelist

Ad blocker detected. Please whitelist us or give premium a try.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print